Fri, Dec 26, 2014, 4:18 PM EST - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

VIVUS Inc. Message Board

  • greatdayforinvestments greatdayforinvestments Jul 12, 2013 1:22 PM Flag

    Avanir Pharmaceuticals PT Raised to $11.00 at Mizuho (AVNR)

    Avanir Pharmaceuticals PT Raised to $11.00 at Mizuho (AVNR)
    Posted by Tammy Falkenburg on Jul 12th, 2013

    Stock analysts at Mizuho upped their price objective on shares of Avanir Pharmaceuticals (NASDAQ: AVNR) from $10.00 to $11.00 in a report issued on Friday, AnalystRatingsNetwork reports. The firm currently has a “buy” rating on the stock. Mizuho’s price target would indicate a potential upside of 149.43% from the stock’s previous close.
    Avanir Pharmaceuticals (NASDAQ: AVNR) opened at 4.42 on Friday. Avanir Pharmaceuticals has a 1-year low of $2.07 and a 1-year high of $4.78. The stock’s 50-day moving average is currently $4.07. The company’s market cap is $641.4 million.
    Avanir Pharmaceuticals (NASDAQ: AVNR) last posted its quarterly earnings results on Wednesday, May 8th. The company reported ($0.12) earnings per share for the quarter, missing the analysts’ consensus estimate of ($0.09) by $0.03. The company had revenue of $17.40 million for the quarter, compared to the consensus estimate of $17.40 million. During the same quarter last year, the company posted ($0.13) earnings per share. Avanir Pharmaceuticals’s revenue was up 74.0% compared to the same quarter last year. On average, analysts predict that Avanir Pharmaceuticals will post $-0.39 earnings per share for the current fiscal year.
    Several other analysts have also recently commented on the stock. Analysts at Cowen and Company raised their price target on shares of Avanir Pharmaceuticals from $8.00 to $12.00 in a research note to investors on Monday. Separately, analysts at Summer Street raised their price target on shares of Avanir Pharmaceuticals from $14.00 to $16.00 in a research note to investors on Monday. They now have a “buy” rating on the stock. Finally, analysts at Wedbush raised their price target on shares of Avanir Pharmaceuticals from $6.00 to $8.00 in a research note to investors on Friday, April 19th.

    Sentiment: Strong Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
VVUS
2.96-0.03(-1.17%)4:00 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.